Osaic Holdings’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14K Buy
143
+25
+21% +$218 ﹤0.01% 7225
2025
Q4
$947 Sell
118
-2,150
-95% -$7.23K ﹤0.01% 7292
2025
Q3
$6.46K Sell
2,268
-19
-0.8% -$58 ﹤0.01% 6613
2025
Q2
$7.23K Buy
2,287
+41
+2% +$133 ﹤0.01% 6345
2025
Q1
$7.14K Buy
2,246
+2,019
+889% +$7.82K ﹤0.01% 5975
2024
Q4
$1.11K Hold
227
﹤0.01% 6811
2024
Q3
$1.02K Hold
227
﹤0.01% 6837
2024
Q2
$1.87K Buy
227
+159
+234% +$994 ﹤0.01% 6621
2024
Q1
$352 Hold
68
﹤0.01% 6887
2023
Q4
$189 Hold
68
﹤0.01% 7051
2023
Q3
$201 Hold
68
﹤0.01% 7152
2023
Q2
$342 Hold
68
﹤0.01% 7124
2023
Q1
$365 Hold
68
﹤0.01% 7190
2022
Q4
$0 Hold
68
﹤0.01% 7330
2022
Q3
$1K Hold
68
﹤0.01% 7012
2022
Q2
$1K Sell
68
-20
-23% -$312 ﹤0.01% 7105
2022
Q1
$2K Hold
88
﹤0.01% 6890
2021
Q4
$1K Sell
88
-871
-91% -$16.2K ﹤0.01% 7207
2021
Q3
$18K Hold
959
﹤0.01% 5849
2021
Q2
$23K Hold
959
﹤0.01% 5572
2021
Q1
$25K Buy
959
+147
+18% +$4.24K ﹤0.01% 5341
2020
Q4
$19K Hold
812
﹤0.01% 5191
2020
Q3
$20K Hold
812
﹤0.01% 4913
2020
Q2
$17K Hold
812
﹤0.01% 4894
2020
Q1
$7K Buy
+812
New +$6.43K ﹤0.01% 5193

Other funds holding LPCN

Osaic Holdings's LPCN Position: Q1 2026 in Review

Osaic Holdings increased its Lipocine (LPCN) stake by 21% in Q1 2026, buying an estimated $218 and bringing the position to 143 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #7225.

Osaic Holdings first reported a position in LPCN in Q1 2020 and has held it in 25 quarters since. The position peaked at $25K in Q1 2021. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Osaic Holdings held 143 shares of Lipocine worth $1.14K as of Q1 2026.
  • Osaic Holdings bought 25 Lipocine shares in Q1 2026, an estimated $218.
  • Lipocine made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7225 holding.
  • Osaic Holdings first reported a position in Lipocine in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Lipocine position peaked at $25K in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.